Your browser doesn't support javascript.
loading
LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer.
Sun, Zeguo; Zhang, Rui; Zhang, Xiao; Sun, Yifei; Liu, Pengpeng; Francoeur, Nancy; Han, Lei; Lam, Wan Yee; Yi, Zhengzi; Sebra, Robert; Walsh, Martin; Yu, Jinpu; Zhang, Weijia.
Afiliação
  • Sun Z; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Zhang R; Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Tianjin, Chi
  • Zhang X; Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Tianjin, Chi
  • Sun Y; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Liu P; Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Tianjin, Chi
  • Francoeur N; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Han L; Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Tianjin, Chi
  • Lam WY; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Yi Z; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Sebra R; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Walsh M; Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
  • Yu J; Cancer Molecular Diagnostics Core, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Cancer Immunology and Biotherapy, Tianjin's Clinical Research Center for Cancer, Tianjin, Chi
  • Zhang W; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA. weijia.zhang@mssm.edu.
Mol Cancer ; 21(1): 147, 2022 07 16.
Article em En | MEDLINE | ID: mdl-35842613
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Escamosas / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos